We are live on
!
Find out more
DCMM
DG Capital Management (Massachusetts) Portfolio holdings
AUM
$102M
1-Year Est. Return
29.14%
This Fund
S&P 500
This Quarter
Est. Return
+4.98%
1 Year Est. Return
+29.14%
3 Year Est. Return
+96.74%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$165M
AUM Growth
–
Cap. Flow
+$165M
Cap. Flow
% of AUM
99.97%
Top 10 Holdings %
Top 10 Hldgs %
27.59%
Holding
56
New
56
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$6.36M |
| 2 |
Gilead Sciences
GILD
|
+$5.44M |
| 3 |
Citigroup
C
|
+$4.4M |
| 4 |
AbbVie
ABBV
|
+$4.24M |
| 5 |
Chubb
CB
|
+$4.18M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.87% |
| 2 | Financials | 20.48% |
| 3 | Communication Services | 9.49% |
| 4 | Consumer Discretionary | 9.28% |
| 5 | Industrials | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRO
26
DELISTED
Marathon Oil Corporation
MRO
| $3.33M | 2.02% |
+96,290
| New | +$3.25M |
|
27
Cisco
CSCO
$477B
| $3.32M | 2.01% |
+136,610
| New | +$3.07M |
|
28
Morgan Stanley
MS
$340B
| $3.18M | 1.93% |
+130,305
| New | +$3.09M |
|
29
Vertex Pharmaceuticals
VRTX
$123B
| $2.81M | 1.7% |
+35,040
| New | +$2.58M |
|
|
ONXX
30
DELISTED
ONYX PHARMACEUTICALS INC
ONXX
| $2.79M | 1.69% |
+32,170
| New | +$2.96M |
|
31
Mondelez International
MDLZ
$80B
| $2.67M | 1.62% |
+93,630
| New | +$2.85M |
|
32
eBay
EBAY
$47.7B
| $2.67M | 1.62% |
+122,459
| New | +$2.78M |
|
33
GSK
GSK
$104B
| $2.64M | 1.6% |
+42,276
| New | +$2.68M |
|
34
Intel
INTC
$508B
| $2.62M | 1.59% |
+108,250
| New | +$2.56M |
|
35
AB InBev
BUD
$166B
| $2.6M | 1.58% |
+28,830
| New | +$2.75M |
|
36
Waters Corp
WAT
$38.9B
| $2.6M | 1.57% |
+25,965
| New | +$2.49M |
|
|
UN
37
DELISTED
Unilever NV New York Registry Shares
UN
| $2.59M | 1.57% |
+65,895
| New | +$2.71M |
|
38
Verisk Analytics
VRSK
$24.2B
| $2.58M | 1.56% |
+43,240
| New | +$2.58M |
|
39
Eli Lilly
LLY
$1.05T
| $2.58M | 1.56% |
+52,530
| New | +$2.86M |
|
|
MRSH
40
Marsh
MRSH
$91.6B
| $2.57M | 1.56% |
+64,388
| New | +$2.52M |
|
41
Microsoft
MSFT
$3.68T
| $2.56M | 1.55% |
+74,000
| New | +$2.42M |
|
42
Stanley Black & Decker
SWK
$15.5B
| $2.51M | 1.52% |
+32,495
| New | +$2.55M |
|
43
Cigna
CI
$71.9B
| $2.5M | 1.51% |
+34,475
| New | +$2.32M |
|
|
LCC
44
DELISTED
US AIRWAYS GROUP INC.
LCC
| $2.24M | 1.36% |
+136,640
| New | +$2.31M |
|
|
NVO
45
Novo Nordisk
NVO
$201B
| $2.2M | 1.33% |
+142,050
| New | +$2.36M |
|
|
MON
46
DELISTED
Monsanto Co
MON
| $2.15M | 1.31% |
+21,805
| New | +$2.28M |
|
47
Amgen
AMGN
$218B
| $2.13M | 1.29% |
+21,590
| New | +$2.24M |
|
48
Diageo
DEO
$51.7B
| $2.12M | 1.28% |
+18,400
| New | +$2.23M |
|
|
DNKN
49
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $1.97M | 1.19% |
+45,975
| New | +$1.85M |
|
|
WBA
50
DELISTED
Walgreens Boots Alliance
WBA
| $1.41M | 0.85% |
+31,890
| New | +$1.55M |
|
Similar funds
LOT
BGA
PCM
EDRAML
EC
SAMNY
BCCM
EIAM
DG Capital Management (Massachusetts)'s Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for DG Capital Management (Massachusetts), which disclosed 56 positions worth $165M. Its ten largest holdings account for 28% of the portfolio.
Its largest position is Biogen: 29,755 shares worth $6.4M.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, followed by Financials and Communication Services.
- DG Capital Management (Massachusetts)'s largest Q2 2013 buy was Biogen: 29,755 shares worth $6.4M.
- DG Capital Management (Massachusetts)'s ten largest holdings make up 28% of its $165M portfolio in Q2 2013.
- DG Capital Management (Massachusetts) disclosed 56 positions in Q2 2013, its first 13F filing on record.
Based on DG Capital Management (Massachusetts)'s 13F filing for Q2 2013, filed 5 Aug 2013.